Discover
ATYR
aTyr Pharma, Inc.
0.59
2 x 0.43
2 x 0.76
bid
ask
-
0.01
1.17%
2 @ 04:00 PM
0.59 -0.00 (0.05%)
| Ytd | -24.67% | |
| 1y | -88.50% |
0.57
day range
0.62
0.40
52 week range
7.29
| Open | 0.60 | Prev Close | 0.60 | Low | 0.57 | High | 0.62 | Mkt Cap | 57.83M |
| Vol | 1.44M | Avg Vol | 2.57M | EPS | -0.74 | P/E | N/A | Forward P/E | -4.33 |
| Beta | 1.10 | Short Ratio | 2.66 | Inst. Own | 63.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.61 | 200-d Avg | 0.78 | 1yr Est | 21.29 |
| Income Statement | |||
| Operating Expenses | 11.44M | ||
| Research and Development Expense | 7.32M | ||
| Selling, General and Administrative Expense | 4.12M | ||
| Operating Income | -11.44M | ||
| Net Income | -10.79M | ||
| Net Income Common Stock | -10.79M | ||
| Net Income Common Stock (USD) | -10.79M | ||
| Consolidated Income | -10.79M | ||
| Net Income to Non-Controlling Interests | -1000 | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -10.79M | ||
| Earning Before Interest & Taxes (USD) | -10.79M | ||
| Weighted Average Shares | 98.04M | ||
| Weighted Average Shares Diluted | 98.04M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.81M | ||
| Cash and Equivalents (USD) | 11.81M | ||
| Investments | 56.51M | ||
| Investments Current | 56.51M | ||
| Trade and Non-Trade Receivables | 477.00K | ||
| Current Assets | 67.58M | ||
| Property, Plant & Equipment Net | 10.13M | ||
| Total Assets | 79.65M | ||
| Debt Current | 1.49M | ||
| Total Debt | 11.70M | ||
| Current Liabilities | 11.70M | ||
| Debt Non-Current | 10.21M | ||
| Total Liabilities | 21.91M | ||
| Accumulated Retained Earnings (Deficit) | -616.96M | ||
| Accumulated Other Comprehensive Income | -70.00K | ||
| Shareholders Equity | 57.93M | ||
| Shareholders Equity (USD) | 57.93M | ||
| Assets Non-Current | 12.08M | ||
| Total Debt (USD) | 11.70M | ||
| Liabilities Non-Current | 10.21M | ||
| Trade and Non-Trade Payables | 2.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 394.00K | ||
| Net Cash Flow from Financing | -142.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.16M | ||
| Capital Expenditure | -138.00K | ||
| Issuance (Repayment) of Debt Securities | -142.00K | ||
| Net Cash Flow from Investing | 11.49M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 11.63M | ||
| Net Cash Flow from Operations | -12.52M | ||
| Share Based Compensation | 1.31M | ||